146 A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol in the Relief of Nasal Symptoms of Perennial Allergic Rhinitis

BACKGROUND: Ciclesonide hydrofluoroalkane nasal aerosol (CIC-HFA) is currently in development as a potential treatment for allergic rhinitis. The objective of this study was to determine the efficacy and safety of CIC-HFA compared to placebo in subjects with perennial allergic rhinitis (PAR). METHOD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mohar, Dale, Berger, William, Raphael, Gordon, LaForce, Craig, Huang, Holly, Desai, Shailesh, Bode, Frederick, Karafilidis, John
Format: Artigo
Idioma:Inglês
Publicat: World Allergy Organization Journal 2012
Matèries:
Abstracts of the XXII World Allergy Congress
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513095/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000411891.75019.97
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars